Phase 4 Asthma Trial, Recruiting NCT06970080 Sponsor: McMaster University Condition: Asthma
Back to Asthma

Phase 4 Asthma Trial, Recruiting

NCT06970080
Recruiting Phase 4

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are able and willing to sign a written consent form agreeing to take part.
  • People who are able and willing to follow the study plan and attend required visits.
  • People aged 18 or older (male or female).
  • People who have been diagnosed with asthma by a lung specialist (respiratory physician).
  • People whose lungs have shown a particular sensitivity or responsiveness in breathing tests within the last 6 months (confirm with trial site for exact test results required).
  • People whose asthma symptoms have been poorly controlled, based on a specific questionnaire score, during the screening period (confirm with trial site).
  • People whose test results during the screening period show signs of a specific type of airway inflammation, measured through a sputum (mucus) sample or a breath test (confirm with trial site for exact values required).

Who may not be able to join:

  • People who currently smoke, vape, or use a pipe, cigar, or marijuana regularly (at least one per day for 30 or more days in the past 12 months).
  • People who are pregnant or breastfeeding.
  • People who do not speak English.
  • People who have taken oral corticosteroid tablets or liquid (steroid medicines taken by mouth) in the past month.
  • People who have received a biologic therapy (a type of specialist injectable medicine for asthma or similar conditions) in the past 6 months.
  • People who are unable to correctly use a metered-dose inhaler (a standard puffer) during the screening period.
  • People who have another lung disease — such as COPD, pulmonary fibrosis, cystic fibrosis, pulmonary arterial hypertension, or tuberculosis — that has required treatment in the past 12 months.
  • People who are unable to have an MRI scan, including those who have metal implants, pacemakers, neurostimulators, aneurysm clips, surgical staples, metallic fragments, or other devices in their body that cannot be removed, or people who experience severe claustrophobia (fear of enclosed spaces) or any other condition that would prevent them from completing an MRI.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
Phase 4 trials study a drug that has already been approved, monitoring long-term safety and effectiveness in real-world use.

Contact this trial

Phone: (905) 522-1155 Ext. 32195

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 4
Sponsor
McMaster University
Registry
ClinicalTrials.gov
Start date
2 June 2025
Est. completion
1 June 2028

Where this trial is recruiting

🇨🇦 Canada

Primary endpoints

Biological response to additional ICS; Biological response to add-on OCS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov